Literature DB >> 25890849

Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells.

Soo-Hyeon Lee1, Dong-Jun Shin2, Sang-Ki Kim3.   

Abstract

Interleukin-15 (IL-15) is a pleiotropic cytokine that plays a pivotal role in both innate and adaptive immunity. IL-15 is also a promising cytokine for treating cancer. Despite the growing importance of the clinical use of IL-15 for immunotherapy, no attempts have been made to generate a recombinant canine IL-15 (rcIL-15) and to examine its effects on the antitumor activities of immune effector cells in dogs. Here, we generated an rcIL-15 protein consisting of Asn-49-Ser-162 with a C-terminal His tag and examined its functions ex vivo in terms of the proliferation and antitumor effects on canine non-B, non-T, large granular natural killer (NK) cells. Non-B, non-T, large granular NK cells rapidly expanded in response to stimulation with rcIL-15 in the presence of IL-2, and a majority of the cells that selectively expanded over 21 days exhibited a CD3(-)CD5(-)CD4(-)CD8(+/-)CD21(-) phenotype. Purified rcIL-15 significantly enhanced the expansion rate of canine NK cells derived from peripheral blood mononuclear cells compared to human IL-15, or culture in the absence of IL-15 for 21 days (p<0.05). Purified rcIL-15 was superior at enhancing the effector function of NK cells compared to human IL-15. The cytotoxic activity against canine thyroid adenocarcinoma (CTAC) cells, interferon-γ production, and the mRNA expression levels of perforin and granzyme B of expanded NK cells cultured with rcIL-15 were significantly elevated compared to those cultured with human IL-15 or without IL-15 (p<0.05). Intravenous administration of rcIL-15 significantly increased the numbers of lymphocytes in the peripheral blood of dogs on days 6, 8, and 11 after injection compared to numbers before administration (p<0.05). The results of this study suggest that the rcIL-15 protein, consisting of Asn-49-Ser-162, enhanced the proliferation and antitumor effects of canine NK cells and promoted the generation of lymphocytes in dogs.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Immunotherapy; Interleukin-15; NK cells; Recombinant protein

Mesh:

Substances:

Year:  2015        PMID: 25890849     DOI: 10.1016/j.vetimm.2015.04.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Effects of three IL-15 variants on NCI-H446 cell proliferation and expression of cell cycle regulatory molecules.

Authors:  Jun-Ying Ding; Zhi-Hua Wang; Zheng-Zheng Zhang; Xu-Ran Cui; Yan-Ying Hong; Qing-Quan Liu
Journal:  Oncotarget       Date:  2017-11-20

2.  Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.

Authors:  T Taki; T Takeichi; K Sugiura; M Akiyama
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

3.  Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.

Authors:  Yoseop Kim; Soo-Hyeon Lee; Cheol-Jung Kim; Je-Jung Lee; Dohyeon Yu; Soomin Ahn; Dong-Jun Shin; Sang-Ki Kim
Journal:  BMC Vet Res       Date:  2019-10-14       Impact factor: 2.741

4.  Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.

Authors:  Katie L Anderson; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-10-19

5.  NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.

Authors:  Jennifer A Foltz; Srinivas S Somanchi; Yanwen Yang; Arianexys Aquino-Lopez; Erin E Bishop; Dean A Lee
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

Review 6.  Immunotherapy for Dogs: Running Behind Humans.

Authors:  Hans Klingemann
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

7.  Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21- Cytotoxic Large Granular Lymphocytes.

Authors:  Soo-Hyeon Lee; Dong-Jun Shin; Yoseop Kim; Cheol-Jung Kim; Je-Jung Lee; Mee Sun Yoon; Tung Nguyen Thanh Uong; Dohyeon Yu; Ji-Youn Jung; Duck Cho; Bock-Gie Jung; Sang-Ki Kim; Guk-Hyun Suh
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

Review 8.  Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy.

Authors:  Alicia A Gingrich; Jaime F Modiano; Robert J Canter
Journal:  J Clin Med       Date:  2019-10-27       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.